WHO ICTRP trial
Assessment of the best absorption of levothyroxine liquid formulation in…
EUCTR2013-001696-21-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2013-001696-21-IT |
|---|---|
| Public title | Assessment of the best absorption of levothyroxine liquid formulation in conjunction with the intake of food |
| Scientific title | Prospective blinded study of the absorption of levothyroxine oral solution (Tirosint ® single-dose oral solution) in patients with hypothyroidism. - TICO |
| Primary sponsor | AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Hypothyrodism;Therapeutic area: Diseases [C] - Hormonal diseases [C19] |
| Interventions | Trade Name: tirosint Product Name: TIROSINT Pharmaceutical Form: Oral solution INN or Proposed INN: LEVOTHYROXINE SODIUM CAS Number: 55-03-8 Other descriptive name: tirosint Pharmaceutical form of the placebo: Oral solution Route of… |
| Registration date | Jul 19, 2013 |
| Secondary IDs | AOBS-2MED-TICO-2013 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: